# Pomegranate Extract Biomarker Study in Osteopenic Women

> **NCT01219140** · PHASE1 · COMPLETED · sponsor: **POM Wonderful LLC** · enrollment: 64 (actual)

## Conditions studied

- Osteopenic Women

## Interventions

- **DIETARY_SUPPLEMENT:** 2 POMx Capsules
- **DIETARY_SUPPLEMENT:** 2 placebo Capsules

## Key facts

- **NCT ID:** NCT01219140
- **Lead sponsor:** POM Wonderful LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-05
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 64 (ACTUAL)
- **Last updated:** 2010-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01219140

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01219140, "Pomegranate Extract Biomarker Study in Osteopenic Women". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01219140. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*